Page last updated: 2024-08-16

suramin and pd 166285

suramin has been researched along with pd 166285 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernacki, RJ; Dimitroff, CJ; Dougherty, TJ; Driscoll, D; Henderson, B; Klohs, W; Klutchko, S; Pera, P; Schroeder, M; Sharma, A; Steinkampf, R; Sumlin, A; Veith, J	1

Other Studies

1 other study(ies) available for suramin and pd 166285

Article	Year
Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy. Investigational new drugs, 1999, Volume: 17, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Capillaries; Cell Division; Cell Line; Combined Modality Therapy; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Hyperkeratosis, Epidermolytic; Inhibitory Concentration 50; Mice; Mice, Inbred C3H; Photochemotherapy; Pyridones; Pyrimidines; Receptor Protein-Tyrosine Kinases; Skin; Suramin; Survival Rate; Time Factors; Tumor Cells, Cultured; Umbilical Veins	1999

Article

Year

Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy.

Investigational new drugs, 1999, Volume: 17, Issue:2

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Capillaries; Cell Division; Cell Line; Combined Modality Therapy; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Hyperkeratosis, Epidermolytic; Inhibitory Concentration 50; Mice; Mice, Inbred C3H; Photochemotherapy; Pyridones; Pyrimidines; Receptor Protein-Tyrosine Kinases; Skin; Suramin; Survival Rate; Time Factors; Tumor Cells, Cultured; Umbilical Veins

1999